GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BioPharma Credit PLC (LSE:BPCR) » Definitions » 5-Year Dividend Growth Rate

BioPharma Credit (LSE:BPCR) 5-Year Dividend Growth Rate : 0.00% (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is BioPharma Credit 5-Year Dividend Growth Rate?

BioPharma Credit's Dividends per Share for the six months ended in Dec. 2024 was $0.02.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

During the past 8 years, the highest 3-Year average Dividends Per Share Growth Rate of BioPharma Credit was 6.50% per year. The lowest was 6.50% per year. And the median was 6.50% per year.

BioPharma Credit's Dividend Payout Ratio for the six months ended in Dec. 2024 was 0.43. As of today, BioPharma Credit's Dividend Yield % is 7.88%.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of BioPharma Credit PLC is 0.71, which seems too high.

Good Sign:

BioPharma Credit PLC stock Dividend Yield % is close to 10-year high.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of BioPharma Credit's 5-Year Dividend Growth Rate

For the Asset Management subindustry, BioPharma Credit's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioPharma Credit's 5-Year Dividend Growth Rate Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, BioPharma Credit's 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where BioPharma Credit's 5-Year Dividend Growth Rate falls into.


;
;

BioPharma Credit 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


BioPharma Credit  (LSE:BPCR) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

BioPharma Credit's Dividend Payout Ratio for the quarter that ended in Dec. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Dec. 2024 )/ EPS without NRI (Q: Dec. 2024 )
=0.018/ 0.042
=0.43

During the past 8 years, the highest Dividend Payout Ratio of BioPharma Credit was 1.13. The lowest was 0.52. And the median was 0.82.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of BioPharma Credit PLC is 0.71, which seems too high.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

BioPharma Credit Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
USD 0.0175002025-04-032025-04-042025-05-07Cash DividendquarterlyUSD:USD 1.000000
USD 0.0175002025-01-302025-01-312025-02-28Cash DividendquarterlyUSD:USD 1.000000
USD 0.0175002024-09-262024-09-272024-10-29Cash DividendquarterlyUSD:USD 1.000000
USD 0.0175002024-07-042024-07-052024-07-31Cash DividendquarterlyUSD:USD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

BioPharma Credit's Dividend Yield (%) for Today is calculated as

Dividend Yield %=Most Recent Full Year Dividend/Current Share Price
=0.07/0.888
=7.88 %

Current Share Price is $0.888.
BioPharma Credit's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.07.

During the past 8 years, the highest Dividend Yield of BioPharma Credit was 8.58%. The lowest was 5.42%. And the median was 7.26%.

Good Sign:

BioPharma Credit PLC stock Dividend Yield % is close to 10-year high.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioPharma Credit 5-Year Dividend Growth Rate Related Terms

Thank you for viewing the detailed overview of BioPharma Credit's 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


BioPharma Credit Business Description

Traded in Other Exchanges
N/A
Address
29 Wellington Street, Central Square, Leeds, GBR, LS1 4DL
BioPharma Credit PLC is an investment company. The investment objective of the company is to generate long-term shareholder returns predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The only reporting segment of the company is the investment in debt assets secured by royalties or other cash flows derived from the sale of approved life sciences products. The company generates revenue in the form of interest income, income from subsidiaries, royalty revenue, make-whole and prepayment income, dividends, and paydown fees. The company earns a majority of its revenue from Investment income.

BioPharma Credit Headlines

No Headlines